Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Genalyte Teams with Scienion to Provide sciFLEXARRAYER Dispensers

Published: Thursday, September 20, 2012
Last Updated: Wednesday, September 19, 2012
Bookmark and Share
Scienion’s automated liquid handling dispenser complements the simplicity, speed and flexibility of the Maverick multiplexed system.

Genalyte, Inc. and Scienion AG have announced an agreement under which Genalyte will market Scienion’s sciFLEXARRAYER™ automated liquid dispensers along with Genalyte’s multiplexed Maverick™ Detection System.

The Maverick platform uses a proprietary silicon chip containing arrays of photonic micro ring sensors to simultaneously analyze multiple proteins, DNA or biomarkers from a single small sample, using a one-step process that automates the washes, incubations, reagents and processing steps associated with other technologies.

Scienion’s sciFLEXARRAYERs are automated, non-contact dispensing systems for ultra-low volume liquid handling of biological samples.

Genalyte is offering customers the sciFLEXARRAYER S5, a robust production unit designed for low maintenance, long term use as a flexible and dependable tool for manufacturing high quality arrays.

Its integrated dispense control and auto-drop function provide users with an easy-to-use, walk-away solution for a variety of liquid dispensing applications.

“After a rigorous search for an automated liquid dispensing system with the precision needed to spot sample material onto the Maverick system’s 30-micron rings, I am pleased to announce this agreement with Scienion,” said Cary Gunn, PhD, CEO of Genalyte.

Gunn continued, “The company’s dependable, ultra low volume liquid handling dispensers allow for highly precise, contact-free drop spotting and are well suited for microarray based applications. We now can offer our customers a comprehensive validated automated system for multiplexed detection and analysis.”

Under the terms of the agreement, Genalyte will market the sciFLEXARRAYER S5 dispenser to its customers and Scienion will retain responsibility for installing and servicing the sciFLEXARRAYER.

Dr. Holger Eickhoff, CEO of Scienion AG, commented, “As a leading provider of advanced automated liquid dispensing systems, we welcome the opportunity to collaborate with multiplexing innovator Genalyte. We view our products as highly complementary and look forward to a productive partnership.”

Separately, Genalyte announced the launch of its Custom Spotting Service. To provide scientists with maximum flexibility to design multiplex assay panels addressing their specific research needs, Genalyte is now offering a cost effective custom spotting service that will load proteins such as antibodies, peptides, biomarkers, cytokines and antigens supplied by customers onto Genalyte chips.

The chips are then returned to the customer in the same ready-to-use chip array format used in Genalyte’s off-the shelf multiplex assay kits, ready to be run on the Maverick Detection System.

The Maverick multiplex system can deliver results from small samples of many types, including serum, plasma, culture media and whole blood. For more information, visit

The Maverick Detection System and its ENA 4 and ENA 6 Assay Kits are currently commercially available to researchers. The assays simultaneously screen for several of the most common auto antibodies found in autoimmune connective tissue disorders, such as systemic lupus erythematosus (SLE).

Assay kits for advanced SLE testing, rheumatoid arthritis and Type I diabetes are available under the Genalyte Technology Access program.

The simplified one-step workflow of the Maverick assays delivers accurate results in 15 minutes, and they can be run using very small volume samples from a variety of matrices, including serum and plasma.

Semi-quantitative results are reported for each analyte, eliminating the need for reflex testing. The Maverick platform has a large dynamic range and excellent sensitivity, with outstanding reproducibility.

For more information about Genalyte, the Maverick platform, the Maverick ENA 4 and ENA 6 Assay Kits, the Technology Access program and Genalyte’s Custom Chip Spotting Service, visit Maverick assays are currently available for research use only.

The Lab-on-a-Chip World Congress will be held September 25-26, 2012 in San Diego, CA. Information about Scienion and Genalyte products will be available at Booth 26.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Detection of Colon Cancer
AIT, BioVendor and SCIENION signed cooperation agreement for early detection of colon cancer.
Saturday, September 27, 2014
SCIENION and Innopsys Agree on a Joint Product Offering for RPPA
Added value for customers combining technologies of both companies into a complete assay solution.
Tuesday, March 26, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Revolutionary Technologies Developed to Improve Outcomes for Lung Cancer Patients
Breath test to detect lung cancer brings oxygen directly to the wound.
NIH Supports New Studies to Find Alzheimer’s Biomarkers in Down Syndrome
Initiative will track dementia onset, progress in Down syndrome volunteers.
Dementia Linked to Deficient DNA Repair
Mutant forms of breast cancer factor 1 (BRCA1) are associated with breast and ovarian cancers but according to new findings, in the brain the normal BRCA1 gene product may also be linked to Alzheimer’s disease.
Using Drug-Susceptible Parasites to Fight Drug Resistance
Researchers at the University of Georgia have developed a model for evaluating a potential new strategy in the fight against drug-resistant diseases.
Boosting Breast Cancer Treatment
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years.
New Gene Map Reveals Cancer’s Achilles’ Heel
Team of researchers switches off almost 18,000 genes
New Discovery Sheds Light on Disease Risk
Gaps between genes interact to influence the risk of acquiring disease.
How Cells ‘Climb’ to Build Fruit Fly Tracheas
Mipp1 protein helps cells sprout “fingers” for gripping.
Research Finding Could Lead to Targeted Therapies for IBD
Findings published online in Cell Reports.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos